Document Detail


Idiopathic intracranial hypertension.
MedLine Citation:
PMID:  20637991     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Idiopathic intracranial hypertension ((IIH) is characterized by increased cerebrospinal fluid pressure of unknown cause. It is predominantly a disease of women in the childbearing years. Although the cause of IIH remains obscure, it has become clear that loss of visual function is common and patients may progress to blindness if untreated. Diagnosis should adhere to the modified Dandy criteria and other causes of intracranial hypertension sought. IIH patient management should include serial perimetry and optic disc grading or photography. The proper therapy can then be selected and visual loss prevented or reversed. Although there are no evidence-based data to guide therapy, there is an ongoing randomized double-blind controlled treatment trial of IIH investigating diet and medical therapy.
Authors:
Michael Wall
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Neurologic clinics     Volume:  28     ISSN:  1557-9875     ISO Abbreviation:  Neurol Clin     Publication Date:  2010 Aug 
Date Detail:
Created Date:  2010-07-19     Completed Date:  2010-10-28     Revised Date:  2013-05-29    
Medline Journal Info:
Nlm Unique ID:  8219232     Medline TA:  Neurol Clin     Country:  United States    
Other Details:
Languages:  eng     Pagination:  593-617     Citation Subset:  IM    
Copyright Information:
Copyright 2010 Elsevier Inc. All rights reserved.
Affiliation:
Department of Neurology, College of Medicine, University of Iowa, Veterans Administration Medical Center, Iowa City, IA 52242, USA. michael-wall@uiowa.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Blindness / diagnosis,  etiology*
Female
Headache / diagnosis,  etiology
Humans
Male
Optic Nerve / pathology
Papilledema / etiology
Pseudotumor Cerebri / complications*,  epidemiology,  etiology,  therapy*
Randomized Controlled Trials as Topic
Risk Factors
Visual Field Tests / methods
Grant Support
ID/Acronym/Agency:
U10 EY017281/EY/NEI NIH HHS; U10 EY017281-01A1/EY/NEI NIH HHS; U10 EY017281-01A1S1/EY/NEI NIH HHS; U10 EY017281-01A1S2/EY/NEI NIH HHS; U10 EY017281-02/EY/NEI NIH HHS; U10 EY017281-03/EY/NEI NIH HHS
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Giant Cell Arteritis.
Next Document:  Transient Monocular Visual Loss.